[Federal Register: June 5, 2007 (Volume 72, Number 107)]
[Notices]
[Page 31076-31078]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr05jn07-54]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Advisory Committee Information Hotline
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that we
have revised the Advisory Committee Information Hotline (the hotline).
The hotline provides the public with access to the most current
information available on FDA advisory committee meetings. This notice
supersedes all previously published announcements of the hotline.
FOR FURTHER INFORMATION CONTACT: Theresa L. Green, Committee Management
Officer (HF-4), Food and Drug Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301-827-1220.
SUPPLEMENTARY INFORMATION: The hotline can be accessed by dialing 1-
800-741-8138 or 301-443-0572. The advisory committee meeting
information and information updates can also be accessed via FDA's
advisory committee calendar at http://www.fda.gov/oc/advisory/accalendar/2007/default.htm
.
Each advisory committee is assigned a 10-digit number. This 10-
digit number will appear in each individual notice of meeting. The
public can obtain information about a particular advisory committee
meeting by using the committee's 10-digit number. Information on the
hotline is preliminary and may change before a meeting is actually
held. The hotline will be updated when such changes are made. The
following is a list of each advisory committee's 10-digit number to be
used when accessing the hotline.
------------------------------------------------------------------------
Advisory Committee 10-Digit Access Number
------------------------------------------------------------------------
Office of the Commissioner
------------------------------------------------------------------------
Pediatric Advisory Committee 8732310001
------------------------------------------------------------------------
Risk Communication Advisory Committee 8732112560
------------------------------------------------------------------------
Science Board to the FDA 3014512603
------------------------------------------------------------------------
Center for Biologics Evaluation and Research
------------------------------------------------------------------------
Allergenic Products Advisory Committee 3014512388
------------------------------------------------------------------------
Blood Products Advisory Committee 3014519516
------------------------------------------------------------------------
[[Page 31077]]
Cellular, Tissue & Gene Therapies Advisory 3014512389
Committee
------------------------------------------------------------------------
Transmissible Spongiform Encephalopathies 3014512392
Advisory Committee
------------------------------------------------------------------------
Vaccines and Related Biological Products 3014512391
Advisory Committee
------------------------------------------------------------------------
Center for Drug Evaluation and Research
------------------------------------------------------------------------
Anesthetic and Life Support Drugs Advisory 3014512529
Committee
------------------------------------------------------------------------
Anti-Infective Drugs Advisory Committee 3014512530
------------------------------------------------------------------------
Antiviral Drugs Advisory Committee 3014512531
------------------------------------------------------------------------
Arthritis Advisory Committee 3014512532
------------------------------------------------------------------------
Cardiovascular and Renal Drugs Advisory 3014512533
Committee
------------------------------------------------------------------------
Dermatologic and Ophthalmic Drugs Advisory 3014512534
Committee
------------------------------------------------------------------------
Drug Safety and Risk Management Advisory 3014512535
Committee
------------------------------------------------------------------------
Endocrinologic and Metabolic Drugs 3014512536
Advisory Committee
------------------------------------------------------------------------
Gastrointestinal Drugs Advisory Committee 3014512538
------------------------------------------------------------------------
Nonprescription Drugs Advisory Committee 3014512541
------------------------------------------------------------------------
Oncologic Drugs Advisory Committee 3014512542
------------------------------------------------------------------------
Peripheral and Central Nervous System 3014512543
Drugs Advisory Committee
------------------------------------------------------------------------
Pharmaceutical Science & Clinical 3014512539
Pharmacology, Advisory Committee for
(formerly Advisory Committee for
Pharmaceutical Science)
------------------------------------------------------------------------
Psychopharmacologic Drugs Advisory 3014512544
Committee
------------------------------------------------------------------------
Pulmonary-Allergy Drugs Advisory Committee 3014512545
------------------------------------------------------------------------
Reproductive Health Drugs, Advisory 3014512537
Committee for
------------------------------------------------------------------------
Center for Food Safety and Applied Nutrition
------------------------------------------------------------------------
Food Advisory Committee 3014510564
------------------------------------------------------------------------
Center for Devices and Radiological Health
------------------------------------------------------------------------
Device Good Manufacturing Practice 3014512398
Advisory Committee
------------------------------------------------------------------------
Medical Devices Advisory Committee (composed of 18 panels)
------------------------------------------------------------------------
Anesthesiology and Respiratory Therapy 3014512624
Devices Panel
------------------------------------------------------------------------
Circulatory System Devices Panel 3014512625
------------------------------------------------------------------------
Clinical Chemistry and Clinical 3014512514
Toxicology Devices Panel
------------------------------------------------------------------------
Dental Products Panel 3014512518
------------------------------------------------------------------------
Ear, Nose, and Throat Devices Panel 3014512522
------------------------------------------------------------------------
Gastroenterology-Urology Devices Panel 3014512523
------------------------------------------------------------------------
General and Plastic Surgery Devices 3014512519
Panel
------------------------------------------------------------------------
General Hospital and Personal Use 3014512520
Devices Panel
------------------------------------------------------------------------
Hematology and Pathology Devices Panel 3014512515
------------------------------------------------------------------------
Immunology Devices Panel 3014512516
------------------------------------------------------------------------
Medical Devices Dispute Resolution Panel 3014510232
------------------------------------------------------------------------
Microbiology Devices Panel 3014512517
------------------------------------------------------------------------
[[Page 31078]]
Molecular and Clinical Genetics Panel 3014510231
------------------------------------------------------------------------
Neurological Devices Panel 3014512513
------------------------------------------------------------------------
Obstetrics-Gynecology Devices 3014512524
------------------------------------------------------------------------
Ophthalmic Devices Panel 3014512396
------------------------------------------------------------------------
Orthopaedic and Rehabilitation Devices 3014512521
Panel
------------------------------------------------------------------------
Radiological Devices Panel 3014512526
------------------------------------------------------------------------
National Mammography Quality Assurance 3014512397
Advisory Committee
------------------------------------------------------------------------
Technical Electronic Product Radiation 3014512399
Safety Standards Committee
------------------------------------------------------------------------
Center for Veterinary Medicine
------------------------------------------------------------------------
Veterinary Medicine Advisory Committee 3014512548
------------------------------------------------------------------------
National Center for Toxicological Research (NCTR)
------------------------------------------------------------------------
Science Advisory Board to NCTR 3014512559
------------------------------------------------------------------------
The hotline will provide the most recent information available on
upcoming advisory committee meetings, guidance for making an oral
presentation during the open public hearing portion of a meeting, and
procedures on obtaining copies of transcripts of advisory committee
meetings. Because the hotline will communicate the most current
information available about any particular advisory committee meeting,
this system will provide interested parties with timely and equal
access to such information. The hotline should also conserve agency
resources by reducing the current volume of inquiries individual FDA
offices and employees must handle concerning advisory committee
schedules and procedures.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.
Dated: May 28, 2007.
Randall W. Lutter,
Associate Commissioner for Policy.
[FR Doc. E7-10738 Filed 6-4-07; 8:45 am]
BILLING CODE 4160-01-S